Lisa Koodie
Overview
Explore the profile of Lisa Koodie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida H, Sato-Dahlman M, Hajeri P, Jacobsen K, Koodie L, Yanagiba C, et al.
Transl Oncol
. 2020 Dec;
14(2):100997.
PMID: 33338875
The PAX3-FOXO1 fusion gene functions as a transactivator and increases expression of many cancer-related genes. These lead to metastases and other unfavorable outcomes for alveolar rhabdomyosarcoma (ARMS) patients. In order...
2.
Yoshida H, Koodie L, Jacobsen K, Hanzawa K, Miyamoto Y, Yamamoto M
Sci Rep
. 2020 Oct;
10(1):17255.
PMID: 33037318
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
3.
Yoshida H, Koodie L, Jacobsen K, Hanzawa K, Miyamoto Y, Yamamoto M
Sci Rep
. 2020 Jan;
10(1):1199.
PMID: 31988291
β-1,4-N-Acetyl-Galactosaminyltransferase 1 (B4GALNT1) encodes the key enzyme B4GALNT1 to generate gangliosides GM2/GD2. GM2/GD2 gangliosides are surface glycolipids mainly found on brain neurons as well as peripheral nerves and skin melanocytes...
4.
Koodie L, Robertson M, Chandrashekar M, Ruth G, Dunning M, Bianco R, et al.
Cancers (Basel)
. 2019 Feb;
11(2).
PMID: 30744019
Oncolytic adenoviruses (Ad) are promising tools for cancer therapeutics. Most Ad-based therapies utilize species C serotypes, with Adenovirus type 5 (Ad5) most commonly employed. Prior clinical trials demonstrated low efficiency...
5.
Ninkovic J, Anand V, Dutta R, Zhang L, Saluja A, Meng J, et al.
Sci Rep
. 2016 Apr;
6:24011.
PMID: 27096260
No abstract available.
6.
Ninkovic J, Jana N, Anand V, Vidhu A, Dutta R, Raini D, et al.
Sci Rep
. 2016 Feb;
6:21094.
PMID: 26891899
Opioid drug abusers have a greater susceptibility to gram positive (Gram (+)) bacterial infections. However, the mechanism underlying opioid modulation of Gram (+) versus Gram (-) bacterial clearance has not...
7.
Koodie L, Yuan H, Pumper J, Yu H, Charboneau R, Ramkrishnan S, et al.
Am J Pathol
. 2014 Feb;
184(4):1073-1084.
PMID: 24495739
Tumor cells secrete factors that stimulate the migration of peripheral blood leukocytes and enhance tumor progression by affecting angiogenesis. In these studies, we investigated the effect of morphine, a known...
8.
Roy S, Ninkovic J, Banerjee S, Charboneau R, Das S, Dutta R, et al.
J Neuroimmune Pharmacol
. 2011 Jul;
6(4):442-65.
PMID: 21789507
Infection rate among intravenous drug users (IDU) is higher than the general public, and is the major cause of morbidity and hospitalization in the IDU population. Epidemiologic studies provide data...
9.
Koodie L, Ramakrishnan S, Roy S
Am J Pathol
. 2010 Jul;
177(2):984-97.
PMID: 20616349
Morphine, a highly potent analgesic agent, is frequently prescribed for moderate to severe cancer pain. In this study, morphine was administered at a clinically relevant analgesic dose to assess tumor...
10.
Martin J, Koodie L, Krishnan A, Charboneau R, Barke R, Roy S
Am J Pathol
. 2010 Jan;
176(2):786-99.
PMID: 20042674
Patients prescribed morphine for the management of chronic pain, and chronic heroin abusers, often present with complications such as increased susceptibility to opportunistic infections and inadequate healing of wounds. We...